Structural basis for improved efficacy of therapeutic antibodies on defucosylation of their Fc glycans
- PMID: 22023369
- PMCID: PMC3258418
- DOI: 10.1111/j.1365-2443.2011.01552.x
Structural basis for improved efficacy of therapeutic antibodies on defucosylation of their Fc glycans
Abstract
Removal of the fucose residue from the N-glycans of the Fc portion of immunoglobulin G (IgG) results in a dramatic enhancement of antibody-dependent cellular cytotoxicity (ADCC) through improved affinity for Fcγ receptor IIIa (FcγRIIIa). Here, we present the 2.2-Å structure of the complex formed between nonfucosylated IgG1-Fc and a soluble form of FcγRIIIa (sFcγRIIIa) with two N-glycosylation sites. The crystal structure shows that one of the two N-glycans of sFcγRIIIa mediates the interaction with nonfucosylated Fc, thereby stabilizing the complex. However, fucosylation of the Fc N-glycans inhibits this interaction, because of steric hindrance, and furthermore, negatively affects the dynamics of the receptor binding site. Our results offer a structural basis for improvement in ADCC of therapeutic antibodies by defucosylation.
© 2011 The Authors. Journal compilation © 2011 by the Molecular Biology Society of Japan/Blackwell Publishing Ltd.
Figures





Similar articles
-
Conformational effects of N-glycan core fucosylation of immunoglobulin G Fc region on its interaction with Fcγ receptor IIIa.Sci Rep. 2017 Oct 23;7(1):13780. doi: 10.1038/s41598-017-13845-8. Sci Rep. 2017. PMID: 29062024 Free PMC article.
-
Importance of the Side Chain at Position 296 of Antibody Fc in Interactions with FcγRIIIa and Other Fcγ Receptors.PLoS One. 2015 Oct 7;10(10):e0140120. doi: 10.1371/journal.pone.0140120. eCollection 2015. PLoS One. 2015. PMID: 26444434 Free PMC article.
-
An atomistic perspective on antibody-dependent cellular cytotoxicity quenching by core-fucosylation of IgG1 Fc N-glycans from enhanced sampling molecular dynamics.Glycobiology. 2020 May 19;30(6):407-414. doi: 10.1093/glycob/cwz101. Glycobiology. 2020. PMID: 31829411
-
Terminal sugars of Fc glycans influence antibody effector functions of IgGs.Curr Opin Immunol. 2008 Aug;20(4):471-8. doi: 10.1016/j.coi.2008.06.007. Epub 2008 Jul 17. Curr Opin Immunol. 2008. PMID: 18606225 Review.
-
The "less-is-more" in therapeutic antibodies: Afucosylated anti-cancer antibodies with enhanced antibody-dependent cellular cytotoxicity.MAbs. 2018 Jul;10(5):693-711. doi: 10.1080/19420862.2018.1466767. MAbs. 2018. PMID: 29733746 Free PMC article. Review.
Cited by
-
Restricted N-glycan conformational space in the PDB and its implication in glycan structure modeling.PLoS Comput Biol. 2013;9(3):e1002946. doi: 10.1371/journal.pcbi.1002946. Epub 2013 Mar 14. PLoS Comput Biol. 2013. PMID: 23516343 Free PMC article.
-
Structure of FcγRI in complex with Fc reveals the importance of glycan recognition for high-affinity IgG binding.Proc Natl Acad Sci U S A. 2015 Jan 20;112(3):833-8. doi: 10.1073/pnas.1418812112. Epub 2015 Jan 5. Proc Natl Acad Sci U S A. 2015. PMID: 25561553 Free PMC article.
-
Comprehensive N-Glycan Mapping using Parallel Reaction Monitoring LC-MS/MS.Pharm Res. 2023 Jun;40(6):1399-1410. doi: 10.1007/s11095-022-03453-1. Epub 2022 Dec 13. Pharm Res. 2023. PMID: 36513905
-
Drifts in N-Linked Glycosylation Result in ADCC Potency Variation of Perjeta® from August 2020 to October 2021 in China.Biomed Res Int. 2022 Apr 30;2022:7868391. doi: 10.1155/2022/7868391. eCollection 2022. Biomed Res Int. 2022. PMID: 35535043 Free PMC article.
-
A synopsis of recent developments defining how N-glycosylation impacts immunoglobulin G structure and function.Glycobiology. 2020 Mar 20;30(4):214-225. doi: 10.1093/glycob/cwz068. Glycobiology. 2020. PMID: 31822882 Free PMC article. Review.
References
-
- Behring E, Kitasato S. Ûber das zustandekommen der Díeptherid-Immunitat und der Tetanus-Immunitat bei Tieren. Dtsch. Med. Wochenschr. 1890;16:1113–1114. - PubMed
-
- Burton DR, Woof JM. Human antibody effector function. Adv. Immunol. 1992;51:1–84. - PubMed
-
- CCP4 The CCP4 suite: programs for protein crystallography. Acta Crystallogr. D Biol. Crystallogr. 1994;50:760–763. - PubMed
-
- DeLano WL. The PyMOL Molecular Graphics System. San Carlos, CA: DeLano Scientific; 2002.
-
- Emsley P, Cowtan K. Coot: model-building tools for molecular graphics. Acta Crystallogr. D Biol. Crystallogr. 2004;60:2126–2132. - PubMed
Publication types
MeSH terms
Substances
Associated data
- Actions
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases